Association between vitamins and risk of brain tumors: A systematic review and dose-response meta-analysis of observational studies

source extracted confidence: high 2026-04-09

Association between vitamins and risk of brain tumors: A systematic review and dose-response meta-analysis of observational studies

Zhang et al., 2022 | Front Nutr | Systematic Review

Citation

Zhang Weichunbai, Jiang Jing, ... Li Wenbin. Association between vitamins and risk of brain tumors: A systematic review and dose-response meta-analysis of observational studies. Front Nutr. 2022;9:935706. doi:10.3389/fnut.2022.935706

Abstract

BACKGROUND: Brain tumor is one of the important causes of cancer mortality, and the prognosis is poor. Therefore, early prevention of brain tumors is the key to reducing mortality due to brain tumors. OBJECTIVE: This review aims to quantitatively evaluate the association between vitamins and brain tumors by meta-analysis. METHODS: We searched articles on PubMed, Cochrane Library, Web of Science, and Embase databases from inception to 19 December 2021. According to heterogeneity, the fixed-effects model or random-effects model was selected to obtain the relative risk of the merger. Based on the methods described by Greenland and Longnecker, we explored the dose-response relationship between vitamins and the risk of brain tumors. Subgroup analysis, sensitivity analysis, and publication bias were also used for the analysis. RESULTS: The study reviewed 23 articles, including 1,347,426 controls and 6,449 brain tumor patients. This study included vitamin intake and circulating concentration. For intake, it mainly included vitamin A, vitamin B, vitamin C, vitamin E, β-carotene, and folate. For circulating concentrations, it mainly included vitamin E and vitamin D in the serum (25-hydroxyvitamin D and α-tocopherol). For vitamin intake, compared with the lowest intakes, the highest intakes of vitamin C (RR = 0.81, 95%CI:0.66-0.99, I 2 = 54.7%, P for heterogeneity = 0.007), β-carotene (RR = 0.78, 95%CI:0.66-0.93, I 2 = 0, P for heterogeneity = 0.460), and folate (RR = 0.66, 95%CI:0.55-0.80, I 2 = 0, P for heterogeneity = 0.661) significantly reduced the risk of brain tumors. For serum vitamins, compared with the lowest concentrations, the highest concentrations of serum α-tocopherol (RR = 0.61, 95%CI:0.44-0.86, I 2 = 0, P for heterogeneity = 0.656) significantly reduced the risk of brain tumors. The results of the dose-response relationship showed that increasing the intake of 100 μg folate per day reduced the risk of brain tumors by 7% (P -nonlinearity = 0.534, RR = 0.93, 95%CI:0.90-0.96). CONCLUSION: Our analysis suggests that the intake of vitamin C, β-carotene, and folate can reduce the risk of brain tumors, while high serum α-tocopherol concentration also has a protective effect on brain tumors. Therefore, vitamins may provide new ideas for the prevention of brain tumors. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, identifier CRD42022300683.

Key Findings

The study reviewed 23 articles, including 1,347,426 controls and 6,449 brain tumor patients. This study included vitamin intake and circulating concentration. For intake, it mainly included vitamin A, vitamin B, vitamin C, vitamin E, β-carotene, and folate. For circulating concentrations, it mainly included vitamin E and vitamin D in the serum (25-hydroxyvitamin D and α-tocopherol). For vitamin intake, compared with the lowest intakes, the highest intakes of vitamin C (RR = 0.81, 95%CI:0.66-0.99

Outcomes Measured

  • Requires manual extraction

Population

Field Value
Population See abstract
Sample Size See abstract
Age Range See abstract
Condition See abstract

MeSH Terms

  • No MeSH terms indexed

Evidence Classification

  • Level: Systematic Review
  • Publication Types: Systematic Review, Journal Article
  • Vertical: vitamin-a

Provenance

Source extracted via PubMed E-utilities API on 2026-04-09